HIV screening in patients with anal condylomatosis. An overview about ethical and legal issues

25.00

COD: 10_11_2021_3731_EP Categorie: , ,

Giovanni Cestaro, Nunzio Velotti, Vincenzo Schiavone, Mario Musella, Maurizio Gentile

Ann Ital Chir, 2021; 10 – Nov. 11

La mia nuova descrizione qui!

Price of a print issue €25.00

HIV screening in patients with anal condylomatosis. An overview about ethical and legal issues

INTRODUCTION: HIV screening in patients with anal condylomatosis. An overview about ethical and legal issues
Although there is a strong evidence of prevalence of condylomata in the HIV-positive population, literature on HIV
prevalence in HIV-unscreened population diagnosed with condylomata is still unconclusive. Our aim is to review literature
about HIV screening and diagnosis of anal condylomata in order to evaluate medical aspects, ethical and legal
issues concerning the management of this disease. We undertook an online search on Pubmed for the keywords “HIV”,
“screening” and “anal condylomata” and 23 papers were analysed, 2 being randomized controlled trial, 11 comparative
studies and 10 reviews. A total of 1270 patients were reviewed. All authors strongly recommend HIV testing in patients
with clinical evidence of anal condylomata. In undeveloped countries with high prevalence of HIV, a proctological evaluation
could be a could represent an unexpected therapeutic option for HIV infected male patients to prevent anal cancer.
Clinical trials and prospective studies are necessary to validate this interesting hypothesis.